417 related articles for article (PubMed ID: 29407687)
21. Cognition in older adults with bipolar disorder: An ISBD task force systematic review and meta-analysis based on a comprehensive neuropsychological assessment.
Montejo L; Torrent C; Jiménez E; Martínez-Arán A; Blumberg HP; Burdick KE; Chen P; Dols A; Eyler LT; Forester BP; Gatchel JR; Gildengers A; Kessing LV; Miskowiak KW; Olagunju AT; Patrick RE; Schouws S; Radua J; Bonnín CDM; Vieta E;
Bipolar Disord; 2022 Mar; 24(2):115-136. PubMed ID: 34978124
[TBL] [Abstract][Full Text] [Related]
22. [Neurocognitive insight in schizophrenia: a meta-analysis].
Potvin S; Pelletier J; Stip E
Sante Ment Que; 2014; 39(2):183-200. PubMed ID: 25590551
[TBL] [Abstract][Full Text] [Related]
23. The interplay of childhood trauma, oxytocin, and impulsivity in predicting the onset of methamphetamine use.
Chang HM; Chen C; Lu ML; Jou S; Santos VHJ; Goh KK
Child Abuse Negl; 2024 Jan; 147():106579. PubMed ID: 38048654
[TBL] [Abstract][Full Text] [Related]
24. The impact of cognitive training in substance use disorder: the effect of working memory training on impulse control in methamphetamine users.
Brooks SJ; Wiemerslage L; Burch KH; Maiorana SA; Cocolas E; Schiöth HB; Kamaloodien K; Stein DJ
Psychopharmacology (Berl); 2017 Jun; 234(12):1911-1921. PubMed ID: 28324119
[TBL] [Abstract][Full Text] [Related]
25. Preliminary evidence concerning the pattern and magnitude of cognitive dysfunction in major depressive disorder using cogstate measures.
Davis MT; DellaGioia N; Matuskey D; Harel B; Maruff P; Pietrzak RH; Esterlis I
J Affect Disord; 2017 Aug; 218():82-85. PubMed ID: 28460315
[TBL] [Abstract][Full Text] [Related]
26. Is cognitive functioning impaired in methamphetamine users? A critical review.
Hart CL; Marvin CB; Silver R; Smith EE
Neuropsychopharmacology; 2012 Feb; 37(3):586-608. PubMed ID: 22089317
[TBL] [Abstract][Full Text] [Related]
27. Neurocognitive deficits are associated with unemployment in chronic methamphetamine users.
Weber E; Blackstone K; Iudicello JE; Morgan EE; Grant I; Moore DJ; Woods SP;
Drug Alcohol Depend; 2012 Sep; 125(1-2):146-53. PubMed ID: 22560676
[TBL] [Abstract][Full Text] [Related]
28. Impact of aerobic exercise on cognitive impairment and oxidative stress markers in methamphetamine-dependent patients.
Zhang K; Zhang Q; Jiang H; Du J; Zhou C; Yu S; Hashimoto K; Zhao M
Psychiatry Res; 2018 Aug; 266():328-333. PubMed ID: 29588062
[TBL] [Abstract][Full Text] [Related]
29. Cognitive function following a major depressive episode: a systematic review and meta-analysis.
Semkovska M; Quinlivan L; O'Grady T; Johnson R; Collins A; O'Connor J; Knittle H; Ahern E; Gload T
Lancet Psychiatry; 2019 Oct; 6(10):851-861. PubMed ID: 31422920
[TBL] [Abstract][Full Text] [Related]
30. Neuropsychological function and delay discounting in methamphetamine-dependent individuals.
Hoffman WF; Moore M; Templin R; McFarland B; Hitzemann RJ; Mitchell SH
Psychopharmacology (Berl); 2006 Oct; 188(2):162-70. PubMed ID: 16915378
[TBL] [Abstract][Full Text] [Related]
31. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence.
Kalechstein AD; Newton TF; Green M
J Neuropsychiatry Clin Neurosci; 2003; 15(2):215-20. PubMed ID: 12724464
[TBL] [Abstract][Full Text] [Related]
32. Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study.
Xu G; Lin K; Rao D; Dang Y; Ouyang H; Guo Y; Ma J; Chen J
J Affect Disord; 2012 Feb; 136(3):328-39. PubMed ID: 22169253
[TBL] [Abstract][Full Text] [Related]
33. Effects of chronic ketamine use on frontal and medial temporal cognition.
Chan KW; Lee TM; Siu AM; Wong DP; Kam CM; Tsang SK; Chan CC
Addict Behav; 2013 May; 38(5):2128-32. PubMed ID: 23435274
[TBL] [Abstract][Full Text] [Related]
34. Cognitive performances associate with measures of white matter integrity in bipolar disorder.
Poletti S; Bollettini I; Mazza E; Locatelli C; Radaelli D; Vai B; Smeraldi E; Colombo C; Benedetti F
J Affect Disord; 2015 Mar; 174():342-52. PubMed ID: 25553397
[TBL] [Abstract][Full Text] [Related]
35. Depression and executive dysfunction contribute to a metamemory deficit among individuals with methamphetamine use disorders.
Casaletto KB; Obermeit L; Morgan EE; Weber E; Franklin DR; Grant I; Woods SP;
Addict Behav; 2015 Jan; 40():45-50. PubMed ID: 25222847
[TBL] [Abstract][Full Text] [Related]
36. Do programs designed to train working memory, other executive functions, and attention benefit children with ADHD? A meta-analytic review of cognitive, academic, and behavioral outcomes.
Rapport MD; Orban SA; Kofler MJ; Friedman LM
Clin Psychol Rev; 2013 Dec; 33(8):1237-52. PubMed ID: 24120258
[TBL] [Abstract][Full Text] [Related]
37. [Subjective cognition in schizophrenia].
Potvin S; Aubin G; Stip E
Encephale; 2017 Feb; 43(1):15-20. PubMed ID: 26923995
[TBL] [Abstract][Full Text] [Related]
38. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
39. The cognitive impairments and psychological wellbeing of methamphetamine dependent patients compared with health controls.
Zhong N; Jiang H; Du J; Zhao Y; Sun H; Xu D; Li C; Zhuang W; Li X; Hashimoto K; Zhao M
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():31-7. PubMed ID: 27085943
[TBL] [Abstract][Full Text] [Related]
40. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.
Meltzer HY; McGurk SR
Schizophr Bull; 1999; 25(2):233-55. PubMed ID: 10416729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
